| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/23/1999 | US5874437 Impotence |
| 02/23/1999 | US5874433 Treating prophylaxis or hypotension induced by cytokine therapy or exposure to bacterial endotoxin by administering a nitric oxide synthase inhibitor |
| 02/23/1999 | US5874422 Reducing the drug side-effect while treating cardiovascular system disorder |
| 02/23/1999 | US5874420 Process for regulating vagal tone |
| 02/23/1999 | US5874286 Tumor proteins |
| 02/23/1999 | US5874273 Nucleic acids for encoding genes and amino acid sequences and hybridization and nucleotide sequences |
| 02/23/1999 | US5874252 Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor |
| 02/23/1999 | US5874227 Binds to corticotropin factor; competitive binding assay for screening ligands |
| 02/23/1999 | US5874224 Growth factor receptor binding protein |
| 02/23/1999 | US5874095 Pharmaceutical active material, non-ionic crosslinked polyacrylamide having a molecular weight of from 1,000,000 to 30,000,000, the polyacrylamide being predispersed in a water-immiscible oil containing a surfactant |
| 02/23/1999 | US5874080 Administering a therapeutic polypeptide antiallergens to inhabit elastase release by neutrophils |
| 02/23/1999 | US5873359 Methods and devices for treating pulmonary vasoconstriction and asthma |
| 02/21/1999 | CA2241428A1 Asp5 |
| 02/20/1999 | CA2241429A1 Cxcr4b: a human splice variant of cxcr4 chemokine receptor |
| 02/20/1999 | CA2213385A1 Method of protecting against coccidiosis infections in poultry |
| 02/19/1999 | CA2241433A1 Novel compounds |
| 02/19/1999 | CA2240631A1 Pigr-1, a member of immunoglobulin gene superfamily |
| 02/18/1999 | WO1999008110A1 Methods and compositions for overcoming resistance to biologic and chemotherapy |
| 02/18/1999 | WO1999007843A1 Human glial cell line-derived neurotrophic factor promoters, vectors containing same, and methods of screening compounds therewith |
| 02/18/1999 | WO1999007836A1 Kinase activating dependent cyclin protein kinases, and their uses |
| 02/18/1999 | WO1999007737A2 Lsr receptor, cloning and uses |
| 02/18/1999 | WO1999007736A2 Lipoprotein-regulating medicaments |
| 02/18/1999 | WO1999007734A2 Hepatitis c inhibitor peptide analogues |
| 02/18/1999 | WO1999007419A1 Dialysis solutions containing water soluble vitamins and nutrients |
| 02/18/1999 | WO1999007414A1 Vectors derived from antibodies for transferring substances into cells |
| 02/18/1999 | WO1999007409A1 Product comprising at least a double stranded rna combined with at least an antiviral agent |
| 02/18/1999 | WO1999007407A1 Heparin-binding growth factor (hbgf) polypeptides |
| 02/18/1999 | WO1999007406A1 C1q AND COLLECTIN RECEPTOR |
| 02/18/1999 | WO1999007405A1 TREATMENT OF ACUTE LUNG INJURY AND FIBROSIS WITH ANTAGONISTS OF αvβ6 |
| 02/18/1999 | WO1999007384A1 Product comprising at least a double stranded rna combined with at least a 6-benzyluracil derivative |
| 02/18/1999 | WO1999007378A1 Nicotine antagonists for nicotine-responsive neuropsychiatric disorders |
| 02/18/1999 | WO1999007376A1 Use of nk-1 receptor antagonists for treating mania |
| 02/18/1999 | WO1999007373A1 Use of nk-1 receptor antagonists for treating mania |
| 02/18/1999 | WO1999007365A1 Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation |
| 02/18/1999 | WO1999007362A1 A PROCESS FOR STABIlIZING LEVOGYRE ASCORBIC ACID (LAA) AND STABLE LAA COMPOSITIONS |
| 02/18/1999 | WO1999007356A1 Nicotine antagonists for neuropsychiatric disorders |
| 02/18/1999 | WO1999007354A2 Compositions, apparatus and methods for facilitating surgical procedures |
| 02/18/1999 | WO1999007342A1 Prolonged release active agent dosage form adapted for gastric retention |
| 02/18/1999 | WO1999007324A2 Conjugates targeted to the interleukin-2 receptor |
| 02/18/1999 | WO1998040055A3 Anti-epileptogenic agents |
| 02/18/1999 | WO1998033491A3 Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase |
| 02/18/1999 | CA2300439A1 Kinase activating dependent cyclin protein kinases, and their uses |
| 02/18/1999 | CA2299554A1 Product comprising at least a double stranded rna combined with at least an antiviral agent |
| 02/18/1999 | CA2299411A1 Heparin-binding growth factor (hbgf) polypeptides |
| 02/18/1999 | CA2299368A1 Conjugates targeted to the interleukin-2 receptor |
| 02/18/1999 | CA2299346A1 Dialysis solutions containing water soluble vitamins and nutrients |
| 02/18/1999 | CA2298849A1 Lipoprotein-regulating medicaments |
| 02/18/1999 | CA2298777A1 Use of nk-1 receptor antagonists for treating mania |
| 02/18/1999 | CA2297736A1 Treatment of acute lung injury and fibrosis with antagonists of .alpha.v.beta.6 |
| 02/18/1999 | CA2274302A1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications |
| 02/18/1999 | CA2268030A1 A process for stabilizing levogyre ascorbic acid (laa) and stable laa compositions |
| 02/17/1999 | EP0897008A2 His5 |
| 02/17/1999 | EP0897004A2 Histidyl tRNA synthetase from Streptococcus pneumoniae (hisS) |
| 02/17/1999 | EP0896615A1 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator |
| 02/17/1999 | EP0896584A2 BIOLOGICALLY ACTIVE PROTEIN (COLLAGEN FRAGMENT HF-COLL-18/514cf) FOR INHIBITING THE GROWTH OF TUMOURS AND CAPILLARY PROFILERATIONS |
| 02/17/1999 | EP0896581A1 Treatment of preeclampsia, eclampsia or preterm labor with calcitonin gene related peptide and related drugs |
| 02/17/1999 | EP0896543A1 Drug for the treatment of tumours |
| 02/17/1999 | EP0896541A1 Silver-based pharmaceutical compositions |
| 02/17/1999 | EP0896538A1 Use of dipeptidyl peptidase iv inhibitors for lowering the blood glucose level in mammals |
| 02/17/1999 | EP0896521A1 Composition, barrier film, and method for preventing contact dermatitis |
| 02/17/1999 | CN1208405A Retroviral protease inhibiting compounds |
| 02/17/1999 | CN1208349A Composition for treating pain |
| 02/17/1999 | CN1208348A Method for treating pain |
| 02/17/1999 | CN1208338A Composition and method for acceleration of wound and burn healing |
| 02/16/1999 | US5872282 Maintain oxygen affinity in blood when stored |
| 02/16/1999 | US5872264 (+)-calanolide A and analogues thereof |
| 02/16/1999 | US5872226 Fibroblast growth factor homologous factor-1 (FHF-1) |
| 02/16/1999 | US5872151 Immunopotentiatory agents and physiologically acceptable salts thereof |
| 02/16/1999 | US5872145 Formulation of 5-HT agonist and NSAID for treatment of migraine |
| 02/16/1999 | US5872133 Method of regulating the immune response |
| 02/16/1999 | US5872127 Method of regulating immune function |
| 02/16/1999 | US5872104 Combinations and methods for reducing antimicrobial resistance |
| 02/16/1999 | US5871973 Cell division regulators |
| 02/16/1999 | US5871967 Cloning of a novel G-Protein coupled 7TM receptor |
| 02/16/1999 | US5871950 Methods of treating autoimmune diseases and transplantation rejection |
| 02/16/1999 | US5871779 Treatment of arthropathies with vanadate compounds or analogues thereof |
| 02/16/1999 | US5871771 Micronized biodegradable particles, process for preparing them and use thereof |
| 02/16/1999 | CA2000913C Family of high affinity antibodies for cancer treatment |
| 02/15/1999 | CA2224096A1 The g-protein coupled receptor hfia041 |
| 02/14/1999 | CA2239264A1 Novel uses |
| 02/13/1999 | CA2240637A1 Novel ratb |
| 02/13/1999 | CA2240627A1 Novel ratc |
| 02/13/1999 | CA2240623A1 Novel rata |
| 02/12/1999 | CA2239837A1 Novel murd |
| 02/12/1999 | CA2239835A1 Human sdr2 cdna clone |
| 02/12/1999 | CA2239819A1 Ftsz |
| 02/11/1999 | WO1999006572A1 Synaptojanin isoform |
| 02/11/1999 | WO1999006562A1 Method enabling readministration of aav vector via immunosuppression of host |
| 02/11/1999 | WO1999006558A1 Human longevity-assurance protein homologs |
| 02/11/1999 | WO1999006442A1 EPO PRIMARY RESPONSE GENE, EPRG3Spt |
| 02/11/1999 | WO1999006437A1 Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006391A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof |
| 02/11/1999 | WO1999006390A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006351A1 Process for converting propargylic amine-n-oxides to enaminones |
| 02/11/1999 | WO1999006070A1 Switchable viscoelastic systems containing galactomannan polymers and borate |
| 02/11/1999 | WO1999006063A1 EPO PRIMARY RESPONSE GENE, EPRG3pt |
| 02/11/1999 | WO1999006060A1 Methods for treating neurological deficits |
| 02/11/1999 | WO1999006035A2 COMBINATIONS OF HMG-CoA REDUCTASE INHIBITORS AND NICOTINIC ACID COMPOUNDS AND METHODS FOR TREATING HYPERLIPIDEMIA ONCE A DAY AT NIGHT |
| 02/11/1999 | WO1999006033A2 An aqueous enteroclysis solution for the treatment of hepatic encephalopathy |
| 02/11/1999 | WO1999006023A1 Ophthalmic compositions containing galactomannan polymers and borate |